Recursion Pharmaceuticals Actifs par action

Que fait Recursion Pharmaceuticals ? Recursion Pharmaceuticals Inc is a biotechnology company based in Salt Lake City, Utah, operating in the Health Care sector. The company went public via an IPO on April 16, 2021. It employs approximately 600 people. Recursion Pharmaceuticals utilizes automation, artificial intelligence, and machine learning technologies to discover novel medicines. The company's platform, referred to as the Recursion Operating System (OS), integrates physical and digital components to map and navigate biological and chemical relationships. The company's approach involves iterative loops between wet lab biology and chemistry data, organized into cycles with computational tools to translate digital hypotheses into validated insights. Recursion Pharmaceuticals has clinical programs including REC-994, REC-2282, REC-4881, and REC-3964. REC-994 is described as an orally bioavailable, superoxide scavenger small molecule being developed for the treatment of cerebral cavernous malformations. The company's website is www.recursion.com. It is listed under the ticker symbol RXRX with ISIN US75629V1044. The company's headquarters are located in Salt Lake City, Utah. Recursion Pharmaceuticals est l'une des entreprises les plus populaires sur Eulerpool.